IMM 1.56% 31.5¢ immutep limited

Ann: New investigator-initiated ph2 trial in Soft Tissue Sarcoma, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 714 Posts.
    lightbulb Created with Sketch. 277
    Whoop-de-fg do. Another trial which won’t start until H2 at the earliest
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.